Sumitomo Mitsui Trust Group’s Regeneron Pharmaceuticals REGN Stock Holding History

Sumitomo Mitsui Trust Group’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$176M	Buy	282,199 +8,530	+3%	+$5.81M	0.1%	186
2026 Q1	$211M	Sell	273,669 -11,362	-4%	-$8.7M	0.14%	139
2025 Q4	$220M	Sell	285,031 -22,258	-7%	-$15.1M	0.13%	143
2025 Q3	$173M	Sell	307,289 -896	-0.3%	-$507K	0.1%	190
2025 Q2	$162M	Buy	308,185 +4,516	+1%	+$2.52M	0.1%	197
2025 Q1	$193M	Buy	303,669 +1,053	+0.3%	+$724K	0.14%	150
2024 Q4	$216M	Buy	302,616 +1,108	+0.4%	+$930K	0.15%	138
2024 Q3	$317M	Buy	301,508 +3,866	+1%	+$4.3M	0.22%	92
2024 Q2	$313M	Sell	297,642 -21,406	-7%	-$20.8M	0.23%	84
2024 Q1	$307M	Sell	319,048 -301	-0.1%	-$286K	0.21%	95
2023 Q4	$280M	Sell	319,349 -8,972	-3%	-$7.39M	0.21%	105
2023 Q3	$270M	Sell	328,321 -5,080	-2%	-$3.99M	0.22%	94
2023 Q2	$240M	Sell	333,401 -39,737	-11%	-$30.6M	0.19%	118
2023 Q1	$307M	Sell	373,138 -6,471	-2%	-$4.88M	0.23%	96
2022 Q4	$274M	Sell	379,609 -11,541	-3%	-$8.52M	0.22%	105
2022 Q3	$269M	Sell	391,150 -8,184	-2%	-$5.15M	0.22%	105
2022 Q2	$236M	Sell	399,334 -7,340	-2%	-$4.77M	0.18%	118
2022 Q1	$284M	Sell	406,674 -25,541	-6%	-$16.2M	0.19%	115
2021 Q4	$273M	Sell	432,215 -37,054	-8%	-$22.8M	0.17%	130
2021 Q3	$284M	Sell	469,269 -82,083	-15%	-$51M	0.18%	123
2021 Q2	$308M	Buy	551,352 +55,497	+11%	+$28.1M	0.18%	126
2021 Q1	$235M	Buy	495,855 +46,254	+10%	+$22.5M	0.15%	162
2020 Q4	$217M	Sell	449,601 -10,971	-2%	-$5.92M	0.14%	163
2020 Q3	$258M	Sell	460,572 -21,435	-4%	-$13M	0.17%	131
2020 Q2	$301M	Buy	482,007 +80,867	+20%	+$45.9M	0.21%	103
2020 Q1	$196M	Sell	401,140 -64,683	-14%	-$26.7M	0.17%	137
2019 Q4	$175M	Sell	465,823 -8,682	-2%	-$2.92M	0.14%	167
2019 Q3	$132M	Buy	474,505 +36,796	+8%	+$10.9M	0.11%	209
2019 Q2	$137M	Buy	437,709 +110,242	+34%	+$36.7M	0.12%	194
2019 Q1	$134M	Buy	327,467 +22,752	+7%	+$9.37M	0.12%	182
2018 Q4	$110M	Buy	304,715 +51,513	+20%	+$18.9M	0.12%	188
2018 Q3	$102M	Buy	253,202 +6,047	+2%	+$2.3M	0.11%	208
2018 Q2	$85.3M	Buy	247,155 +23,567	+11%	+$7.37M	0.1%	222
2018 Q1	$77M	Buy	223,588 +3,812	+2%	+$1.33M	0.1%	226
2017 Q4	$82.6M	Buy	219,776 +2,867	+1%	+$1.16M	0.11%	210
2017 Q3	$97M	Sell	216,909 -3,131	-1%	-$1.49M	0.14%	174
2017 Q2	$108M	Buy	220,040 +3,258	+2%	+$1.43M	0.16%	152
2017 Q1	$84M	Buy	216,782 +780	+0.4%	+$289K	0.13%	186
2016 Q4	$79.3M	Buy	216,002 +637	+0.3%	+$242K	0.13%	186
2016 Q3	$86.6M	Buy	215,365 +387	+0.2%	+$155K	0.14%	169
2016 Q2	$75.1M	Buy	214,978 +757	+0.4%	+$292K	0.13%	192
2016 Q1	$77.2M	Buy	214,221 +8,770	+4%	+$3.61M	0.14%	170
2015 Q4	$113M	Sell	205,451 -1,717	-0.8%	-$930K	0.2%	117
2015 Q3	$96.4M	Buy	207,168 +3,272	+2%	+$1.76M	0.19%	127
2015 Q2	$104M	Sell	203,896 -12,534	-6%	-$6.12M	0.19%	131
2015 Q1	$97.7M	Buy	216,430 +28,461	+15%	+$12.1M	0.18%	133
2014 Q4	$76.8M	Sell	187,969 -2,110	-1%	-$830K	0.15%	163
2014 Q3	$68.5M	Sell	190,079 -158	-0.1%	-$53K	0.14%	178
2014 Q2	$53.7M	Sell	190,237 -5,915	-3%	-$1.75M	0.11%	222
2014 Q1	$58.9M	Buy	196,152 +1,985	+1%	+$612K	0.12%	196
2013 Q4	$54M	Sell	194,167 -8,177	-4%	-$2.35M	0.11%	210
2013 Q3	$63.3M	Sell	202,344 -1,400	-0.7%	-$368K	0.14%	173
2013 Q2	$45.8M	Buy	+203,744	New	+$47.4M	0.1%	229

Other funds holding REGN

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

MCI

McDonald Capital Investors Orinda, California $1.37B AUM 1.88% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group's REGN Position: Q2 2026 in Review

Sumitomo Mitsui Trust Group increased its Regeneron Pharmaceuticals (REGN) stake by 3.1% in Q2 2026, buying an estimated $5.81M and bringing the position to 282,199 shares worth $176M. The position accounts for 0.1% of the portfolio, ranked #186.

Sumitomo Mitsui Trust Group first reported a position in REGN in Q2 2013 and has held it in 53 quarters since. The position peaked at $317M in Q3 2024. 518 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

Sumitomo Mitsui Trust Group held 282,199 shares of Regeneron Pharmaceuticals worth $176M as of Q2 2026.
Sumitomo Mitsui Trust Group bought 8,530 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $5.81M.
Regeneron Pharmaceuticals made up 0.1% of Sumitomo Mitsui Trust Group's portfolio in Q2 2026, its #186 holding.
Sumitomo Mitsui Trust Group first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
Sumitomo Mitsui Trust Group's Regeneron Pharmaceuticals position peaked at $317M in Q3 2024.
518 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Sumitomo Mitsui Trust Group's 13F filing for Q2 2026, filed 30 Jul 2026.